sales@theinsightpartners.com
+1-646-491-9876 +44-20-8125-4005

Large Molecules Drug Substance Cdmo Market Scope And Analysis

  • Report Code : TIPRE00040667
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Large Molecules Drug Substance CDMO Market Analysis Report 2025 to 2031

Buy Now

Large Molecules Drug Substance CDMO Market Report Large Molecules Drug Substance CDMO Market Size and Share Large Molecules Drug Substance CDMO Market Scope and Analysis

Large Molecules Drug Substance CDMO Market Report Scope

Report Attribute Details
Market size in 2024 US$ XX million
Market Size by 2031 US$ XX Million
Global CAGR (2025 - 2031) 8.1%
Historical Data 2021-2023
Forecast period 2025-2031
Segments Covered By Service
  • Contract Manufacturing
  • Contract Development
By Source
  • Mammalian
  • Microbial
By End-user
  • Biotech Companies
  • CRO
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Eurofins Scientific
  • WuXi Biologics
  • Samsung Biologics
  • Catalent Inc
  • Rentschler Biopharma SE
  • AGC Biologics
  • Recipharm AB
  • Siegfried Holding AG
  • Boehringer Ingelheim
  • FUJIFILM Diosynth Biotechnologies
    		•